Chun-Su Lee
Comptroller/Controller/Auditor at NOVMETAPHARMA CO., LTD.
Net worth: 222 677 $ as of 2024-05-30
Chun-Su Lee active positions
| Companies | Position | Start | End |
|---|---|---|---|
| NOVMETAPHARMA CO., LTD. | Comptroller/Controller/Auditor | 2015-03-30 | - |
NovMetaHealth Co. Ltd.
 NovMetaHealth Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of NovMetaPharma Co., Ltd., NovMetaHealth Co. Ltd. develops and manufactures products related to metabolic diseases. The company is based in Seoul, South Korea. The South Korean company was founded in 2016. Seon-Wook Hwang has been the CEO of the company since 2016. NovMetaHealth Co. was acquired by NovMetaPharma Co., Ltd. on March 10, 2022 for $12.61 million. | Comptroller/Controller/Auditor | 2018-11-30 | - |
Career history of Chun-Su Lee
Training of Chun-Su Lee
| Korea University | Graduate Degree |
Statistics
International
| South Korea | 4 |
Operational
| Comptroller/Controller/Auditor | 2 |
| Graduate Degree | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| NOVMETAPHARMA CO., LTD. | Health Technology |
| Private companies | 1 |
|---|---|
NovMetaHealth Co. Ltd.
NovMetaHealth Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of NovMetaPharma Co., Ltd., NovMetaHealth Co. Ltd. develops and manufactures products related to metabolic diseases. The company is based in Seoul, South Korea. The South Korean company was founded in 2016. Seon-Wook Hwang has been the CEO of the company since 2016. NovMetaHealth Co. was acquired by NovMetaPharma Co., Ltd. on March 10, 2022 for $12.61 million. | Health Technology |
- Stock Market
- Insiders
- Chun-Su Lee
- Experience
